chrisvoncsefalvay/vaers-outcomes huggingface dataset:
mental clarity declined moderately/ Brain fog; Extremely weak with no residual energy; Fatigue, Still has extreme fatigue; Still suffering from brain fog; Rash that looked like Roseolovirus or Erythematous; Rash on abdominal area; Fever; Body felt hot; Sore arm; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Body felt hot), RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous), CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog), ASTHENIA (Extremely weak with no residual energy) and RASH (Rash on abdominal area) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 013L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Latex allergy.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced FEELING HOT (Body felt hot), VACCINATION SITE PAIN (Sore arm) and CHILLS (Chills). On 20-Feb-2021, the patient experienced PYREXIA (Fever). On 22-Feb-2021, the patient experienced RASH (Rash on abdominal area). On 23-Feb-2021, the patient experienced RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous). On 20-Jul-2021, the patient experienced FATIGUE (Fatigue, Still has extreme fatigue) and FEELING ABNORMAL (Still suffering from brain fog). On an unknown date, the patient experienced CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog) and ASTHENIA (Extremely weak with no residual energy). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at a dose of 1 dosage form. At the time of the report, FEELING HOT (Body felt hot), CONFUSIONAL STATE (mental clarity declined moderately/ Brain fog), ASTHENIA (Extremely weak with no residual energy), RASH (Rash on abdominal area), VACCINATION SITE PAIN (Sore arm), CHILLS (Chills) and PYREXIA (Fever) had resolved with sequelae, RASH ERYTHEMATOUS (Rash that looked like Roseolovirus or Erythematous) had not resolved and FATIGUE (Fatigue, Still has extreme fatigue) and FEELING ABNORMAL (Still suffering from brain fog) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Feb-2021, Body temperature: 100.5 f (High) 100.5 F.         No concomitant medications were provided by the reporter.   Treatment information was not provided.   This case was linked to MOD-2021-023499 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 20-Jul-2021: Significant Follow up
Received flu vaccination in left deltoid intramuscular 09/30/11 about 0545 am. Next morning 10/01/11 noted reddened follicular rash on arms/legs and face. Itching started on 10/03/11. Contacted employee health about symptoms 10/11/11 about 0830 am. Reviewed current meds. with employee and covering employee health physician. Dr. felt symptoms related to ace inhibitor request employee contact primary care physician who stopped lisinopril.
Developed redness and swelling and warmth R arm 95 x 140 cm. Went to ED and rec'd KEFLEX 500mg QID x 1 wk.
12/25/2022 Woke up around 6 am not feeling well. Had headache, earache, productive cough, congestion, and fatigue. Took at home COVID-19 test and it was negative. Woke up 12/26/2022 at 3AM, tested again, and it was negative. Symptoms continued to worsen.  Called PCP on 12/27/2022 and was prescribed Paxlovid. Began Paxlovid and symptoms began to improve. All my symptoms have improved but still having breathing issues. Went back into PCP and was put on prednisone and it has helped resolve breathing issues
WAS DIAGNOSED WITH EMPHYSEMA IN MAY 2021; This spontaneous report was received from a consumer (patient's wife) and refers to a male patient of unspecified age. The patient's pertinent medical history, concomitant medications, past drug reactions or allergies were not reported.  On an unknown date in 2010 (reported as "12 years ago"), the patient received one dose (reported as "1 dose") of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) (concentration, scheme vaccination frequency, route of administration, anatomical site of application, lot number and expiration date were not provided) as prophylaxis.  On an unspecified date in May 2021, the patient was diagnosed with emphysema.  The outcome of the event was not reported. The causality assessment between the emphysema event and pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) was reported as no connection (not related).
Severe, copious, frequent diarrhea with vomiting and fussiness.  Diarrhea was up to 20 times a day until 1/25/17 at which time it decreased to 3 times and was not entirely liquid.
Date:  3/24/2021                                                                                            Subjective Patient is a 42 y.o. female who was seen at COVID Vaccine Clinic today for her first  dose of the COVID 19 vaccination.    She was given the Pfizer vaccination in the right deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience lightheadedness.  She denied rash, hives, welts, difficulty breathing, difficulty swallowing, wheezing, throat tightness, hoarseness, stridor, itching, facial swelling, lip swelling and tongue swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to blood pressure abnormality  and rapid progression of symptoms.   PMH: asthma r/t seasonal allergies     ALLERGY REVIEW OF SYSTEMS:  Patient denies chills, fever, malaise/fatigue, facial swelling, sore throat, frequent throat clearing, eyes watering, eyes itching, cough, chest tightness, shortness of breath, wheezing, rash, hives, itching of skin, vomiting, abdominal pain, muscle aches, joint pain, dizziness and headaches    + lightheaded:     Previous Reactions: none that she is aware of.  Had dizziness/lightheaded with ear piercing.     Objective    Vitals Vitals:   03/24/21 0951 03/24/21 0955 03/24/21 0959 BP: (!) 166/111 (!) 150/100 (!) 142/72 Pulse: 66 57 63 Resp: 18 14   SpO2: 100% 100% 100%          Physical Exam Constitutional:      General: She is not in acute distress.    Appearance: Normal appearance. She is well-developed. She is not diaphoretic.  HENT:     Mouth/Throat:     Mouth: Mucous membranes are moist.     Pharynx: Oropharynx is clear.  Eyes:     Conjunctiva/sclera: Conjunctivae normal.  Cardiovascular:     Rate and Rhythm: Normal rate and regular rhythm.     Pulses: Normal pulses.     Heart sounds: Normal heart sounds.  Pulmonary:     Effort: Pulmonary effort is normal. No respiratory distress.     Breath sounds: Normal breath sounds. No wheezing.     Comments: Speaking full sentences Skin:    General: Skin is warm and dry.  Neurological:     General: No focal deficit present.     Mental Status: She is alert and oriented to person, place, and time.     Gait: Gait normal.  Psychiatric:        Mood and Affect: Mood is anxious (slight).        Behavior: Behavior normal.        Thought Content: Thought content normal.        Judgment: Judgment normal.     Improved with rest/reclined.  Pt able to sit up and stand w/o dizziness/lightheadedness.     Assessment/Plan  Treatment included: water and close monitoring Follow up response to treatment: excellent. Patient discharge: Stable to go home and follow up with PCP.  Differential Diagnosis: Vaccine-Related Anxiety (include misc mental health) and Red flag symptoms (CP, SOB, NVD, Visual/Neuro concerns)     Anxiety mixed with pseudo mild vasovagal syndrome. Pt improved and did well. Pt aware of option of getting her vaccine done here in the bay next time if she would like. Recommend 30 minute observation.   F/up with pcp otherwise.     3/24/2021 9:48 AM
HYPOTENSION 4/28/2023 FEMALE URETHRAL STRICTURE HYPOTENSION 4/28/2023 SPINAL STENOSIS OF LUMBAR SPINE HYPOTENSION 4/28/2023 FUSION OF LUMBOSACRAL SPINE
Nervous about the 2nd dose; Slightly dizzy; Developed a fast heart beat; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Mar-2021 and was forwarded to Moderna on 22-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Slightly dizzy), TACHYCARDIA (Developed a fast heart beat) and NERVOUSNESS (Nervous about the 2nd dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concomitant products included LEVOTHYROXINE, ACETYLSALICYLIC ACID (ASPIRIN 81), VITAMIN D NOS, FISH OIL, ZINC, MAGNESIUM, PROBIOTICS NOS, ELDERBERRY [SAMBUCUS NIGRA] and ASCORBIC ACID (VITAMIN C ACID) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced DIZZINESS (Slightly dizzy) and TACHYCARDIA (Developed a fast heart beat). On 22-Mar-2021, the patient experienced NERVOUSNESS (Nervous about the 2nd dose). On 09-Mar-2021, DIZZINESS (Slightly dizzy) and TACHYCARDIA (Developed a fast heart beat) had resolved. At the time of the report, NERVOUSNESS (Nervous about the 2nd dose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included multi vitamin over 50  On 09 Mar 2021, the patient was also preparing for colonoscopy test for the next day. Second dose was scheduled on 06 Apr 2021.  No treatment information was provided.
Low fever by 4 pm; progressed to higher fever by 7 pm; progressed to painful earache right ear; pain in upper stomach. Symptoms lasted until apprx 5 am the flwg morning which is when explosive diarrhea began and remained for three days. No appetite the entire time.
Frequent dizziness not associated with a change in position or movement of the head. Began 2 days after receiving vaccine along with other common side effects such as body aches, fatigue, headache. All other side effects resolved within a few days of receiving the shot except for the dizziness. Dizziness has improved but is not completely gone as of 02/17/2021.
Underneath BOTH of my eyes are red and puffy and swollen. It started at when I woke up at 5am and stayed exactly the same all day and it is now 8:35pm
Provider ordered MMR and Varivax. vaccine administered was Proquad and Varivax.
Child began high pitched cry 4 hrs p/#1 DTP given. Cry lasted for 1 hr; Low-grade fever & soreness at inject site present for 1st day.
First dose given to a 15 year old; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose given to a 15 year old) in a 15-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027AZI A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose given to a 15 year old). At the time of the report, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (First dose given to a 15 year old) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medication information was provided. No concomitant medication information was provided.
This spontaneous report was received from a pharmacist concerning unspecified number of patients of unknown age and gender. No concurrent conditions or medical history were reported. On 10-SEP-2015, unspecified patients were vaccinated with unspecified doses of improperly stored VAQTA (Lot # L017757 Expiration date: 08-APR-2018) (dose, route and anatomical location of administration were not reported). No concomitant therapy was provided. No adverse effects were reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
07/10/03: Left upper arm swollen and red at DTaP site administered on 07/09/03. Pt states pain to site. Left arm=8.5 inches. Right arm=6.75 inches. Benadryl, Tylenol or Motrin and Keflex (for 2 days) were ordered.
Case previously recorded as MA2009-4578. Case report received from a physician, via Novartis Medical Communication, on 17 NOV 2009. Patient (gender unknown) under 3 year-old was vaccinated with S-OIV FLUVIRIN (batch no. unknown) i.m., on 13 NOV 2009. No adverse event was reported. MedCom reference no.: NA09-008308.
No reactions to the vaccine, minor pain only. Two days later I got a sore throat and got progressively worst, had respiratory issues, at the 2nd day headaches, I tested positive with a COVID-19 home test. On Sunday I tested negative, next day tested positive. I was positive for 10 days. The first two days I tested positive I had like flu symptoms, I was in bed for 2 days, after that I felt almost completely normal. I had tele-visit with the doctor. I asked for PAXLOVID, but doctor say no to take it, I continued isolation. I still have chest congestion ever since then.
Patient called the nurse because she felt some chest pain (non-cardiac) and dizziness. On-site EMS responded. Vitals are listed below. She said she felt better when EMS arrived. She was checked out to be safe, and released to go home.
10:45am  as client was leaving, she stated that her lips were alittle tingly .  came back in to clinic and waited then she complained that her tongue was a little itchy.  11:00am  Gave Benadryl 50mg IM to right arm.  sat in clinic x 30 mins.  during that time, she did say she was better, just tired   called a family member to pick her up.
Initially a large wheal at the site which expanded rapidly and began to itch.  Within days the entire arm erupted in a papular urticarial rash with areas of edema. Within days of that, a flat red itching rash spread across torso and all limbs, in areas confluent and other areas reticular pattern.  A skin biopsy was done and showed an eosinophilic reaction. The flat rash and the papular rash were treated with antihistamines and steroids. The papular rash on the arm injected is still unresolved.
After receiving vaccinations and bicillin shot. Patient was  instructed to sit for 15 mins. During that time patient was noted to have hives and urticaria. Patient was then sent to medical assessment for further evaluation where he was given Benadryl and Epinephrine and EMS was called to transfer the patient to the ED.
Nausea, subjective fever at 104F, dizziness, blurry vision, vomiting, chills, SOB.
vaccine_brand=Pfizer / BioNTech, product=COVID 19 Treatment; vaccine_brand=Pfizer / BioNTech, product=COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Physician). The reporter is the patient.  A 68-year-old male patient received BNT162b2 (BNT162B2), on 30Dec2020 at 07:30 as dose 1, single (Batch/Lot number: unknown), in left arm, on 06Oct2021 at 14:00 as dose 2, single (Batch/Lot number: unknown), in left arm, on 19Jan2022 at 08:00 as dose 3, single (Batch/Lot number: unknown), in left arm and on 06Apr2022 at 13:30 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 68 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Hypertension" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset Jun2022, outcome "unknown" and all described as "vaccine_brand=Pfizer / BioNTech, product=COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included treatment with paxlovid from 22Jun2022 to 26Jun2022.  Clinical course: It was reported that the patient did not take any other medications within 2 weeks.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events and the suspect drug BNT162B2.
This spontaneous case was reported by a consumer and describes the occurrence of NASOPHARYNGITIS (Cold) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced NASOPHARYNGITIS (Cold). At the time of the report, NASOPHARYNGITIS (Cold) outcome was unknown. Not Provided. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. No treatment information was provided.
Itching started in late evening of March 3, the day of shot.  The next day rash was on back, feet, arms, hands, and legs, with intense itching and raised bumps and blisters. Went to Urgent Care was told it was shingles and given Mometasone Furote crream. Used cream but found no relief.  On March 31 called Medical Doctor, he recommended a Dermatologist.  On April 1, 2021 I saw the Dermatologist for first time and was told it was a Covid rash, caused by the shot I had taken.  At this time the rash was over most of my body with my feet and back being the worst. I was given Betamethasone Valer Ointment for itching and pain.  On April 22, 2021, two biopsies were performed on back. Medication was changed to Triamcinolone Cream for itching and pain.  Rash was still spreading and none of the medicines were helping with the pain or itching.  On May 6, 2021 lab results confirmed Lichen Planus. Medicines were not helping with the itching.  The steroid creams seemed to cause more itching and spreading.  On July 4th, 2021 I woke up to no itching or pain.  There is lots of scaring from large patches of the rash.
Fever; swelling at injection with redness to elbow for a week; swelling at injection with redness to elbow for a week; extreme joint pain; severe headache; Missed worked for both shots; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 50 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 02Dec2020 (Lot number: EL0140) at the age of 50 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious), outcome "recovered", described as "Fever"; VACCINATION SITE SWELLING (non-serious), ERYTHEMA (non-serious), outcome "recovered" and all described as "swelling at injection with redness to elbow for a week"; ARTHRALGIA (non-serious), outcome "recovered", described as "extreme joint pain"; HEADACHE (non-serious), outcome "recovered", described as "severe headache"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "recovered", described as "Missed worked for both shots". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of pyrexia, vaccination site swelling, erythema, arthralgia, headache, loss of personal independence in daily activities.  Additional information: The patient received  dose 2 on 06Jan2021, lot number EK9231, administrator route reported was intramuscular on left arm. No other vaccine received in four weeks. All adverse reactions were felt except myocarditis. Fever, swelling at injection with redness to elbow for a week, extreme joint pain, severe headache, all for 2 days before subsiding. Missed worked for both shots. No treatment received for adverse event. No covid prior vaccination. Patient tested positive for covid post vaccination.  Follow-up attempts are completed. No further information is expected.
pain at her left arm injection site; Moderna Covid-19 vaccine booster dose given more than 12 hours after first dose withdrawn from vial; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain at her left arm injection site) and EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine booster dose given more than 12 hours after first dose withdrawn from vial) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for Product used for unknown indication: Pfizer vaccine (Pfizer vaccine as her two primary series shots) on 30-Mar-2021 and Pfizer vaccine (Pfizer vaccine as her two primary series shots). Past adverse reactions to the above products included No adverse event with Pfizer vaccine and Pfizer vaccine.    On 02-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine booster dose given more than 12 hours after first dose withdrawn from vial). On an unknown date, the patient experienced VACCINATION SITE PAIN (pain at her left arm injection site). At the time of the report, VACCINATION SITE PAIN (pain at her left arm injection site) and EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine booster dose given more than 12 hours after first dose withdrawn from vial) outcome was unknown.            The patient reported that she saw the vial of the Moderna COVID-19 vaccine, that it first had a dose taken from the vial on 01 March 2022 and that her dose from the same vial was taken out at 7:30 AM on 02 March 2022. Patient got this information from a sticker that the provider placed on the side of the vial that her Moderna COVID-19 booster dose came from. No concomitant medications were reported.  Treatment information was not provided.
12 hours after receiving vaccine; exhaustion, sore throat, mild cough, severe joint aches
Lymph nodes in the neck and under the armpit have swelled up. Tingling sensation in the arm. Neck is sore. Alleviated by ibuprofen. Swelling seems to be subsiding.
Patient came into clinic to have the back of the right arm above elbow assessed by a nurse. Redness and swelling noted to be the diameter of a tennis ball; warm to touch. Var vaccine given SQ in this arm on 06/21/2017. Pt educated about s/sx of var administration, instructed to apply cold compress to site,and take Tylenol or Motrin for pain. And in the event that sx do not improve or any further concerns, to follow up with physician.
Numbness left side of face with burning and numbness left arm and leg on May 4.  The right side arm and leg less numbness.  Burning and pain left and right side of hip (2021).  Difficult digestion end of 2021 and into 2022 with constipation.  Overactive bladder with sweating and redness in face at end of 2021 and into 2022.  Sweating when eating and brushing teeth with numbness going down body.  Problems swallowing late summer and through the fall 2022.  Trouble sleeping fall 2022 and into 2023.  Depression and anxiety starting  fall  2022 and into 2023.  Today still overactive bladder with numbness and some redness in face and left side with constipation and diarrhea on and off.  Diagnosis:  Small Fiber Neuropathy  Diagnosed through MRI February 2023
Unknown symptom onset. Treatment includes: ISP, labs, admission with assessment, and aerobika.
Side effects of the injection site were supposed to go away after a few days. It's been almost 4 days since my injection, and the area is still red and inflamed.  The soreness is still present, and the skin around the area feels hot to the touch and tight. Sometimes the area has a slight throbbing to it. Other than that, I feel no other symptoms, but I was a bit concerned with this.